Effects of subchronic clozapine treatment on long-term potentiation in rat prefrontal cortex.

Eur Neuropsychopharmacol

Nervous System Research, Novartis Pharma Inc., CH-4002 Basel, Switzerland.

Published: August 2004

Several studies postulated an interaction of clozapine with N-methyl-D-aspartate (NMDA) receptor-mediated transmission. We previously showed that acute clozapine application on rat prefrontal cortex (PFC) slices increased NMDA receptor-dependent long-term potentiation (LTP) in the prelimbic (PL) area. The present study explores the effects of subchronic clozapine treatment on LTP in the same brain area. After 21 days of treatment (30 mg/kg per day, via drinking water), rats were sacrificed and slices from the PFC were prepared for electrophysiological investigations. To this end, extracellular field potentials in the layer II-V pathway were recorded. In contrast to our previous study with acute application on the slice, subchronic clozapine treatment attenuated LTP as compared to non-treated animals. We interpret these findings to suggest that prolonged treatment with clozapine might result in a compensatory response to the acute facilitating action of clozapine on LTP-mediating processes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euroneuro.2003.10.006DOI Listing

Publication Analysis

Top Keywords

subchronic clozapine
12
clozapine treatment
12
effects subchronic
8
long-term potentiation
8
rat prefrontal
8
prefrontal cortex
8
clozapine
7
treatment
5
treatment long-term
4
potentiation rat
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!